S. Korea’s KT&G Launches KT&G Life Sciences To Steer Pharma Business
This article was originally published in PharmAsia News
South Korea’s KT&G, a tobacco and ginseng conglomerate, said it has renamed its Mazence unit to become KT&G Life Sciences to spearhead its expansion in the pharmaceutical business.
You may also be interested in...
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.